Additional European Equity News
Bayer (BAYN GY) - Co. and Kumquat Biosciences have entered a global exclusive licence and collaboration in precision oncology; focus on developing a Kras G12D Inhibitor Kumquat to receive total payment of up to USD 1.3bln (Newswires)
Bellway (BWY LN) - FY (GBP): Revenue 2.76bln, +17% Y/Y. For FY26, expects to maintain broadly flat avg. outlet number. (Newswires)
Entain (ENT LN) - H1 (GBP): EBITDA 583mln, +11% Y/Y, NGR 2.62bln (prev. 2.55bln Y/Y), Revenue 2.59bln (prev. 2.52bln Y/Y). Introduces FY25 EBITDA guidance in the range of GBP 1.1-1.15bln. H1 performance supports upgraded expectation of about 7% online NGR growth on constant currency basis. Highlights that H2 has started well, in line with upgraded guidance. On 12 August, Pierre Bouchut was appointed as permanent non-executive Chair. (Newswires)
Page (PAGE LN) - H1 (GBP): Revenue 798.4mln (prev. 898mln Y/Y). Announced interim dividend of 5.36p/shr, in line with 2024. (Newswires)
UBS (UBSG SW) - A bookrunner said share sale priced at CHF 31.46 (Newswires)
12 Aug 2025 - 07:10- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts